The RegenKit®-Wound Gel-2 permits autologous platelet rich plasma (PRP) and thrombin serum (ATS) to be rapidly prepared from a small volume of the patient’s blood that is drawn at the time of treatment for use in the treatment of wounds, such as diabetic ulcers, leg ulcers, pressure ulcers, and for the management of mechanically or surgically debrided wounds.

The simple, safe and efficient point of care preparation of autologous platelet rich plasma Device Technology. All Regen™ tubes consist of pharmaceutical-grade class I borosilicate and use vacuum for automated blood collection. The hallmark of the Regen™ technology is a thixotropic separating gel composed of a mixture of polymers for gravimetric plasma separation (elimination of RBC and WBC). RegenTHT, Regen BCT and A-CP are devices designed for the preparation of PRP and contain a sodium citrate anticoagulant solution above the separating gel. The RegenATS device does not contain anticoagulant. In this device, the plasma coagulates and a serum rich in activated thrombin is extracted from the plasma clot. Regen Lab devices intended for PRP preparation consist of evacuated glass tubes containing a thixotropic gel with a specific density designed for platelet or platelet and MNC isolation, and anticoagulant solution. The gel acts as a mechanical separator of blood components, and sodium citrate solution as blood anticoagulant. Thixotropy is a physical property of some gels which are thick under static condition, become more fluid when submitted to physical stress (in this case, the centrifugal force) and regain their original consistency when the physical stress stops. With this vacuum system, blood is gently collected into the tube and mixed with an anticoagulant by gentle inversion. The blood-filled device is centrifuged at 1500 g for 5 (A-CP and Regen BCT) or 9 minutes.